As above, the microneedling rationale rests on studies of other compounds (PMID 23960389, PMID 40225275), not on AHK-Cu data
Clin Exp Pharmacol Physiol 1977
The biggest concern about these unregulated peptides is the lack of adequate human clinical evidence for the uses they are being marketed for, says Rita Jew, PharmD, president at the Institute for Safe Medication Practices in San Francisco
The STEP 1 trial, published in the New England Journal of Medicine, demonstrated 14.9 percent mean body weight reduction with the 2.4mg weekly dose over 68 weeks, compared to just 2.4 percent with placebo
Most people notice an energy shift within the first day or two
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey